HOME
Leading the way to a cure

PRESS RELEASES

ALLIANCE FOR LUPUS RESEARCH COMMITS $500,000 TO CUTTING-EDGE GENETIC RESEARCH

March 8, 2011

The Alliance for Lupus Research (ALR) is proud to announce funding of an important new study to identify lupus susceptibility genes in multiple ethnicities, including African Americans, who are three times more likely than Caucasians to have the disease. The study, part of the SLE Genetics Consortium (SLEGEN), is among the few to concentrate so heavily on non-Caucasian populations and will employ a powerful new technology, called the ImmunoChip, allowing for a significantly broader evaluation while utilizing the most current and comprehensive information about human DNA. The ALR was the only organization to recommend researchers include lupus information on the chip, which was previously designed for other autoimmune diseases, and to stipulate the study be expanded to include non-Caucasian ethnicities.

 

“We are proud to advocate for and fund such an important study geared toward understanding the genetic basis of lupus in diverse populations,” said Ken Farber, executive director, Alliance for Lupus Research. “The ALR is the only organization to support a study like this.  We believe that such cutting-edge research is moving us one step closer to a cure for this debilitating disease.”

 

The ImmunoChip will allow researchers to test an unprecedented quarter of a million genetic markers in systemic lupus erythematosus (SLE).  Because the ImmunoChip is being employed by researchers studying other autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, scientists will have the opportunity to evaluate the common shared genetic risk factors across many autoimmune disorders. 

 

We are hopeful about the potential this research holds, and proud to be leading the way to a cure.


ALLIANCE FOR LUPUS RESEARCH COMMITS $500,000 TO CUTTING-EDGE GENETIC RESEARCH

March 8, 2011

The Alliance for Lupus Research (ALR) is proud to announce funding of an important new study to identify lupus susceptibility genes in multiple ethnicities, including African Americans, who are three times more likely than Caucasians to have the disease. The study, part of the SLE Genetics Consortium (SLEGEN), is among the few to concentrate so heavily on non-Caucasian populations and will employ a powerful new technology, called the ImmunoChip, allowing for a significantly broader evaluation while utilizing the most current and comprehensive information about human DNA. The ALR was the only organization to recommend researchers include lupus information on the chip, which was previously designed for other autoimmune diseases, and to stipulate the study be expanded to include non-Caucasian ethnicities.

 

“We are proud to advocate for and fund such an important study geared toward understanding the genetic basis of lupus in diverse populations,” said Ken Farber, executive director, Alliance for Lupus Research. “The ALR is the only organization to support a study like this.  We believe that such cutting-edge research is moving us one step closer to a cure for this debilitating disease.”

 

The ImmunoChip will allow researchers to test an unprecedented quarter of a million genetic markers in systemic lupus erythematosus (SLE).  Because the ImmunoChip is being employed by researchers studying other autoimmune diseases such as rheumatoid arthritis and multiple sclerosis, scientists will have the opportunity to evaluate the common shared genetic risk factors across many autoimmune disorders. 

 

We are hopeful about the potential this research holds, and proud to be leading the way to a cure.



1.5 million

people in the U.S. have Lupus.

100 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software